Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.

Chen LY, Bigger JT, Hickey KT, Chen H, Lopez-Jimenez C, Banerji MA, Evans G, Fleg JL, Papademetriou V, Thomas A, Woo V, Seaquist ER, Soliman EZ.

Am J Hypertens. 2015 Oct 16. pii: hpv172. [Epub ahead of print]

PMID:
26476086
2.

Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study.

Schwartz AV, Chen H, Ambrosius WT, Sood A, Josse RG, Bonds DE, Schnall AM, Vittinghoff E, Bauer DC, Banerji MA, Cohen RM, Hamilton BP, Isakova T, Sellmeyer DE, Simmons DL, Shibli-Rahhal A, Williamson JD, Margolis KL.

J Clin Endocrinol Metab. 2015 Nov;100(11):4059-66. doi: 10.1210/jc.2015-1215. Epub 2015 Aug 25.

PMID:
26305617
3.

Glucagon-like peptide-1 as predictor of body mass index and dentate gyrus neurogenesis: neuroplasticity and the metabolic milieu.

Coplan JD, Syed S, Perera TD, Fulton SL, Banerji MA, Dwork AJ, Kral JG.

Neural Plast. 2014;2014:917981. doi: 10.1155/2014/917981. Epub 2014 Nov 23.

5.

Efficacy and risk of hypoglycemia with use of insulin glargine or comparators in patients with cardiovascular risk factors.

Blonde L, Baron MA, Zhou R, Banerji MA.

Postgrad Med. 2014 May;126(3):172-89. doi: 10.3810/pgm.2014.05.2766.

PMID:
24918802
6.

Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agents.

Banerji MA, Baron MA, Gao L, Blonde L.

Postgrad Med. 2014 May;126(3):111-25. doi: 10.3810/pgm.2014.05.2761.

PMID:
24918797
7.

Pheochromocytoma: a review.

Tsirlin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA.

Maturitas. 2014 Mar;77(3):229-38. doi: 10.1016/j.maturitas.2013.12.009. Epub 2014 Jan 5. Review.

PMID:
24472290
8.

Diabetes and bone health.

Antonopoulou M, Bahtiyar G, Banerji MA, Sacerdote AS.

Maturitas. 2013 Nov;76(3):253-9. doi: 10.1016/j.maturitas.2013.04.004. Epub 2013 Apr 28. Review.

PMID:
23628280
9.

Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial.

Bray GA, Smith SR, Banerji MA, Tripathy D, Clement SC, Buchanan TA, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Schwenke DC, Stentz FB, Reaven PD, DeFronzo RA.

Diabetes Obes Metab. 2013 Oct;15(10):931-7. doi: 10.1111/dom.12099. Epub 2013 May 7.

PMID:
23551856
10.

Hypopituitarism in the elderly.

Antonopoulou M, Sharma R, Farag A, Banerji MA, Karam JG.

Maturitas. 2012 Aug;72(4):277-85. doi: 10.1016/j.maturitas.2012.05.002. Epub 2012 Jun 20. Review.

PMID:
22727068
11.

Non-insulin injectable treatments (glucagon-like peptide-1 and its analogs) and cardiovascular disease.

Lebovitz HE, Banerji MA.

Diabetes Technol Ther. 2012 Jun;14 Suppl 1:S43-50. doi: 10.1089/dia.2012.0022.

PMID:
22650224
12.

Corticotropin releasing factor (CRF) and obesity.

Sharma R, Banerji MA.

Maturitas. 2012 May;72(1):1-3. doi: 10.1016/j.maturitas.2012.01.015. Epub 2012 Feb 27. No abstract available.

PMID:
22377185
13.

Chronic kidney disease and diabetes.

Pyram R, Kansara A, Banerji MA, Loney-Hutchinson L.

Maturitas. 2012 Feb;71(2):94-103. doi: 10.1016/j.maturitas.2011.11.009. Epub 2011 Dec 3. Review.

PMID:
22137331
14.

Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus.

Kruger DF, Boucher JL, Banerji MA.

Postgrad Med. 2011 Jul;123(4):54-62. doi: 10.3810/pgm.2011.07.2304. Review.

PMID:
21680989
15.

Chronobiology impacts response to antihypertensive drug regimen in type 2 diabetes.

Friedman EA, Banerji MA.

Diabetes Care. 2011 Jun;34(6):1438-9. doi: 10.2337/dc11-0576. No abstract available.

16.

Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys.

Coplan JD, Abdallah CG, Mathew SJ, Shungu DC, Mao X, Smith EL, Kaufman D, Gorman JM, Owens MJ, Nemeroff CB, Banerji MA, Rosenblum LA, Kral JG.

Physiol Behav. 2011 Jul 6;103(5):535-9. doi: 10.1016/j.physbeh.2011.03.020. Epub 2011 Apr 1.

17.

Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: a retrospective analysis of the GALIANT study.

Banerji MA, Purkayastha D, Francis BH.

Diabetes Res Clin Pract. 2010 Nov;90(2):182-90. doi: 10.1016/j.diabres.2010.06.022. Epub 2010 Jul 23.

PMID:
20655609
18.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group.

Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30. Erratum in: Lancet. 2010 Oct 30;376(9751):1466.

19.

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Calles-Escandón J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, Bonds DE, Fonseca VA, Ismail-Beigi F, Banerji MA, Failor A, Hamilton B.

Diabetes Care. 2010 Apr;33(4):721-7. doi: 10.2337/dc09-1471. Epub 2010 Jan 26.

20.

Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.

DeFronzo RA, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven P, Schwenke DC, Stentz FD, Tripathy D; ACT NOW Study Group.

Diabetologia. 2010 Mar;53(3):435-45. doi: 10.1007/s00125-009-1614-2. Epub 2009 Dec 10.

PMID:
20012012
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk